Business Context and Reporting Period
This Form 8-K was filed by Social Capital Suvretta Holdings Corp. III (trading symbol: DNAC) on September 24, 2021. The registrant is a Cayman Islands corporation and an emerging growth company. The filing reports corporate governance changes effective as of the report date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the appointment of a director and related compensatory arrangements rather than financial performance.
Material Changes
- Board Appointment: Uma Sinha, PhD, was appointed to the Board of Directors, effective September 24, 2021. She was designated as an independent director.
- Committee Assignments: Dr. Sinha was appointed to the audit committee, compensation committee, and nominating and corporate governance committee.
- Committee Resignation: Chamath Palihapitiya resigned from his position as a member of the audit committee effective September 24, 2021.
Guidance, Outlook, and Agreements
In connection with her appointment, Dr. Sinha entered into three key agreements:
- Letter Agreement: Dr. Sinha agreed to vote shares in favor of the initial business combination and facilitate liquidation if no combination occurs within the required timeframe.
- Indemnity Agreement: Provides contractual indemnification to Dr. Sinha.
- Restricted Stock Unit (RSU) Award: Grants 30,000 RSUs contingent upon the consummation of an initial business combination and shareholder approval of an equity plan. These units vest upon the business combination and settle between the vesting date and March 15 of the following year.
The Company will reimburse Dr. Sinha for reasonable out-of-pocket expenses. No other transactions or arrangements requiring disclosure under Item 404(a) of Regulation S-K were identified.
Investor Verification Checklist
- Verify the independence status of Dr. Sinha under Nasdaq Capital Market rules.
- Confirm the terms of the 30,000 RSU grant and the specific conditions for vesting and settlement.
- Review the attached Exhibits 10.1, 10.2, and 10.3 for complete legal terms of the agreements.
- Monitor the status of the Company's search for an initial business combination, as the RSUs are contingent on this event.